SCHEMBL22765656

SCHEMBL22765656

C[C@@H]1CN(c2cccc(F)c2)C[C@H](C)N1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.48
ALOX5 P09917 1/20 0.46
C1S P09871 2/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
GSK3B P49841 1/20 0.42
OPRM1 P35372 1/20 0.41
FAAH O00519 1/20 0.40
MGLL Q99685 1/20 0.40
GRM2 Q14416 1/20 0.39
HSD11B1 P28845 2/20 0.39
MAOB P27338 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FADS1 O60427 1/20 0.38
VCP P55072 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R1 P27986 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14567596 0.81 ADRA2C (0.56) C1SOPRM1GRM2MEN1KMT2A
SCHEMBL22765905 0.81 ADRB1 (0.50) ALOX5OPRM1MGLLMAOBL3MBTL1
SCHEMBL22765947 0.79 ALDH1A1 (0.54) CYP1A2CYP2D6
SCHEMBL12663253 0.77 BPTF (0.48) BPTFALOX5OPRM1MEN1KMT2A
SCHEMBL18435994 0.77 BPTF (0.48) BPTFALOX5OPRM1MEN1KMT2A
SCHEMBL22210494 0.77 BPTF (0.46) BPTFALOX5C1SFAAHMGLL
SCHEMBL26256372 0.77 BPTF (0.51) BPTFALOX5C1SFAAHMGLL
SCHEMBL20180729 0.75 DGAT1 (0.41) CYP1A2KMT2A
SCHEMBL1482843 0.74 LMNA (0.45) ALOX5OPRM1MEN1KMT2A
SCHEMBL29991931 0.74 BPTF (0.53) BPTFALOX5C1SFAAHMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345711-B2 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones Impact Therapeutics (Shanghai), Inc (CN) 2022-05-31 US disclosed
US-20200385394-A1 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES Impact Therapeutics (Shanghai), Inc (CN) 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345711-B2 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones WEE1, WEE2, CCNE1 BPTF 2769/4885ALOX5 3909/4885C1S 4542/4885
US-20200385394-A1 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES WEE1, WEE2, CCNE1 BPTF 2769/4885ALOX5 3909/4885C1S 4542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.